Gulubova Maya Vladova, Ivanova Koni Vancho
Department of General and Clinical Pathology, Trakia University, Medical Faculty, Stara Zagora, Bulgaria.
Open Access Maced J Med Sci. 2019 Dec 10;7(23):3944-3949. doi: 10.3889/oamjms.2019.715. eCollection 2019 Dec 15.
Inflammation that occurred in the tumor microenvironment was characterized by abundant macrophage infiltration, playing role in innate immunity. Multinucleate giant cells (MGCs) occur in a variety of inflammatory, hyperplastic, and neoplastic thyroid disorders. They also have been recognized as a feature of papillary thyroid carcinoma (PTC).
The aim of this study was to evaluate cases of PTC for the presence of macrophages, and estimate CD68+ TAMs density in tumor stroma, margin and the surrounding tissue. We assessed also MGCs.
Macrophages and MGCs densities were correlated with clinicopathologic parameters to assess the possible prognostic significance. We investigated 56 patients immunohistochemically and immunofluorescence with antibodies against CD68 and IL-17.
A statistically significant correlation was established between PTC patients in III stage, containing many MGCs, and PTC in I and II stage, with many MGCs. Eighty Percent of patients in III stage showed many MGCs in comparison with patients in I and II stage, where many MGCs were found only in 21,1% (χ = 6.189, p = 0.013).
Our study demonstrates that the increased density of MGCs is associated with advanced stage of PTC, and therefore with tumor progression and that cases of PTC should be carefully screened for their presence.
肿瘤微环境中发生的炎症以丰富的巨噬细胞浸润为特征,在先天免疫中发挥作用。多核巨细胞(MGCs)出现在各种炎症性、增生性和肿瘤性甲状腺疾病中。它们也被认为是甲状腺乳头状癌(PTC)的一个特征。
本研究的目的是评估PTC病例中巨噬细胞的存在情况,并估计肿瘤基质、边缘和周围组织中CD68 +肿瘤相关巨噬细胞(TAMs)的密度。我们还评估了MGCs。
将巨噬细胞和MGCs的密度与临床病理参数相关联,以评估其可能的预后意义。我们用抗CD68和IL-17抗体对56例患者进行了免疫组织化学和免疫荧光研究。
在含有许多MGCs的III期PTC患者与含有许多MGCs的I期和II期PTC患者之间建立了统计学上的显著相关性。与I期和II期患者相比,III期患者中有80%显示有许多MGCs,而在I期和II期患者中,仅21.1%发现有许多MGCs(χ = 6.189,p = 0.013)。
我们的研究表明,MGCs密度增加与PTC的晚期有关,因此与肿瘤进展有关,并且应该仔细筛查PTC病例中MGCs的存在情况。